Assignee
UNIQURE IP BV
NL·30 granted patents·18 pending applications·133 citations·filing 2013–2025
Top patents by PatentIndex Score
48 records- 0197US9580691B2Baculoviral vectors comprising repeated coding sequences with differential codon biasesUNIQURE IP BV·Filed 2014·Granted Feb 28, 2017·33 cites·22 claims
- 0296US9708627B2Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAVUNIQURE IP BV·Filed 2015·Granted Jul 18, 2017·18 cites·21 claims
- 0396US9260724B2Optimization of expression of parvoviral rep and cap proteins in insect cellsUNIQURE IP BV·Filed 2014·Granted Feb 16, 2016·34 cites·25 claims
- 0494US11306291B2AAV vectors produced by insect cells comprising REP52 and REP78 coding sequences with differential codon biasesUNIQURE IP BV·Filed 2018·Granted Apr 19, 2022·6 cites·19 claims
- 0594US2026035674A1Aav vectors produced by insect cells comprising rep52 and rep78 coding sequences with differential codon biasesUNIQURE IP BV·Filed 2025·Application pending·0 cites
- 0692US11371044B2RNAi induced huntingtin gene suppressionUNIQURE IP BV·Filed 2020·Granted Jun 28, 2022·5 cites·22 claims
- 0792US11060070B2Mutated rep encoding sequences for use in AAV productionUNIQURE IP BV·Filed 2019·Granted Jul 13, 2021·5 cites·29 claims
- 0889US10174321B2RNAI induced huntingtin gene suppressionUNIQURE IP BV·Filed 2015·Granted Jan 8, 2019·16 cites·15 claims
- 0988US10533188B2Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAVUNIQURE IP BV·Filed 2018·Granted Jan 14, 2020·2 cites·20 claims
- 1087US10767180B2RNAi induced huntingtin gene suppressionUNIQURE IP BV·Filed 2018·Granted Sep 8, 2020·4 cites·18 claims
- 1187US10253301B2Removal of contaminating viruses from AAV preparationsUNIQURE IP BV·Filed 2017·Granted Apr 9, 2019·2 cites·29 claims
- 1286US2023416778A1Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aavUNIQURE IP BV·Filed 2023·Application pending·0 cites
- 1383US11667931B2AAV capsid production in insect cellsUNIQURE IP BV·Filed 2020·Granted Jun 6, 2023·2 cites·13 claims
- 1482US12486496B2AAV vectors produced by insect cells comprising Rep52 and Rep78 coding sequences with differential codon biasesUNIQURE IP BV·Filed 2022·Granted Dec 2, 2025·0 cites·19 claims
- 1580US10837027B2Further improved AAV vectors produced in insect cellsUNIQURE IP BV·Filed 2015·Granted Nov 17, 2020·2 cites·21 claims
- 1678US10190098B2AAV vectors produced by insect cells comprising REP52 and REP78 coding sequences with differential codon biasesUNIQURE IP BV·Filed 2015·Granted Jan 29, 2019·1 cites·19 claims
- 1777US11613765B2Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAVUNIQURE IP BV·Filed 2020·Granted Mar 28, 2023·0 cites·44 claims
- 1876US11021762B2DNA impurities in a composition comprising a parvoviral virionUNIQURE IP BV·Filed 2015·Granted Jun 1, 2021·1 cites·11 claims
- 1974US10865423B2Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAVUNIQURE IP BV·Filed 2020·Granted Dec 15, 2020·0 cites·15 claims
- 2074US2024398988A1RNAi induced C9ORF72 suppression for the treatment of ALS/FTDUNIQURE IP BV·Filed 2024·Application pending·0 cites
- 2173US11452749B2Means and methods for AAV gene therapy in humansUNIQURE IP BV·Filed 2018·Granted Sep 27, 2022·1 cites·10 claims
- 2273US2023119344A1Rnai induced huntingtin gene suppressionUNIQURE IP BV·Filed 2022·Application pending·0 cites
- 2372US10138496B2Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAVUNIQURE IP BV·Filed 2018·Granted Nov 27, 2018·0 cites·17 claims
- 2470US12285451B2Means and methods for AAV gene therapy in humansUNIQURE IP BV·Filed 2022·Granted Apr 29, 2025·0 cites·11 claims
- 2569US9988645B2Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAVUNIQURE IP BV·Filed 2017·Granted Jun 5, 2018·0 cites·18 claims
- 2669US8952144B2Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAVUNIQURE IP BV·Filed 2013·Granted Feb 10, 2015·0 cites·39 claims
- 2768US10400221B2Mutated rep encoding sequences for use in AAV productionUNIQURE IP BV·Filed 2018·Granted Sep 3, 2019·0 cites·30 claims
- 2867US10286087B2ImmunoadsorptionUNIQURE IP BV·Filed 2017·Granted May 14, 2019·1 cites·16 claims
- 2967US2024093231A1Aav capsid production in insect cellsUNIQURE IP BV·Filed 2023·Application pending·0 cites
- 3066US12448628B2Further improved AAV vectors produced in insect cellsUNIQURE IP BV·Filed 2020·Granted Oct 21, 2025·0 cites·20 claims
- 3166US2019218523A1Removal of contaminating viruses from aav preparationsUNIQURE IP BV·Filed 2019·Application pending·0 cites
- 3265US2021353776A1ImmunoadsorptionUNIQURE IP BV·Filed 2021·Application pending·0 cites
- 3364US2026000721A1Means and methods for aav gene therapy in humansUNIQURE IP BV·Filed 2025·Application pending·0 cites
- 3464US2021332447A1Dna impurities in a composition comprising a parvoviral virionUNIQURE IP BV·Filed 2021·Application pending·0 cites
- 3563US2025340878A1METHOD AND MEANS TO DELIVER miRNA TO TARGET CELLSUNIQURE IP BV·Filed 2025·Application pending·0 cites
- 3662US9885022B2Mutated rep encoding sequences for use in AAV productionUNIQURE IP BV·Filed 2015·Granted Feb 6, 2018·0 cites·17 claims
- 3761US2023265434A1Gene constructs for silencing angiopoietin-like 3 (angptl3) and uses thereofUNIQURE IP BV·Filed 2022·Application pending·0 cites
- 3860US2022010314A1Rnai induced reduction of ataxin-3 for the treatment of spinocerebellar ataxia type 3UNIQURE IP BV·Filed 2021·Application pending·0 cites
- 3960US2021330813A1Rnai induced c9orf72 suppression for the treatment of als/ftdUNIQURE IP BV·Filed 2021·Application pending·0 cites
- 4058US11033639B2ImmunoadsorptionUNIQURE IP BV·Filed 2019·Granted Jun 15, 2021·0 cites·25 claims
- 4158US2021371862A1METHOD AND MEANS TO DELIVER miRNA TO TARGET CELLSUNIQURE IP BV·Filed 2021·Application pending·0 cites
- 4256US2020199625A1RNAi induced reduction of ataxin-3 for the treatment of Spinocerebellar ataxia type 3UNIQURE IP BV·Filed 2019·Application pending·0 cites
- 4354US2022213482A1Targeting misspliced transcripts in genetic disordersUNIQURE IP BV·Filed 2022·Application pending·0 cites
- 4454US2022025433A1Companion diagnostic to monitor the effects of gene therapyUNIQURE IP BV·Filed 2021·Application pending·0 cites
- 4552US11780886B2Modified viral vectors and methods of making and using the sameUNIQURE IP BV·Filed 2020·Granted Oct 10, 2023·0 cites·12 claims
- 4651US12319924B2Liver-specific viral promoters and methods of using the sameUNIQURE IP BV·Filed 2021·Granted Jun 3, 2025·0 cites·22 claims
- 4751US12214053B2Methods of improving adeno-associated viral transductionUNIQURE IP BV·Filed 2020·Granted Feb 4, 2025·0 cites·8 claims
- 4847US2016243260A1Treatment of neurological diseases using adeno-associated virus (AAV) comprising AAV-5 capsid proteinsUNIQURE IP BV·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when UNIQURE IP BV files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →